share_log

Barclays Maintains Overweight on Exscientia, Lowers Price Target to $10

Benzinga ·  Oct 17, 2023 20:17

Barclays analyst Peter Lawson maintains Exscientia (NASDAQ:EXAI) with a Overweight and lowers the price target from $12 to $10.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment